1. Home
  2. GME vs GKOS Comparison

GME vs GKOS Comparison

Compare GME & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameStop Corporation

GME

GameStop Corporation

HOLD

Current Price

$21.94

Market Cap

10.7B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$156.28

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GME
GKOS
Founded
1996
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electronics Distribution
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
8.7B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
GME
GKOS
Price
$21.94
$156.28
Analyst Decision
Sell
Strong Buy
Analyst Count
1
12
Target Price
$13.50
$126.92
AVG Volume (30 Days)
4.0M
768.7K
Earning Date
06-09-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
133.33
N/A
EPS
0.66
N/A
Revenue
$3,629,900,000.00
$507,442,000.00
Revenue This Year
$18.98
$23.32
Revenue Next Year
N/A
$27.43
P/E Ratio
$33.67
N/A
Revenue Growth
N/A
32.33
52 Week Low
$19.94
$73.16
52 Week High
$28.10
$157.71

Technical Indicators

Market Signals
Indicator
GME
GKOS
Relative Strength Index (RSI) 48.12 69.73
Support Level $21.09 $96.44
Resistance Level $22.02 N/A
Average True Range (ATR) 0.57 6.17
MACD 0.04 0.70
Stochastic Oscillator 43.88 78.97

Price Performance

Historical Comparison
GME
GKOS

About GME GameStop Corporation

GameStop Corp offers games, collectibles, and entertainment products through its stores and ecommerce platforms. Its products include Hardware and accessories offering new and pre-owned gaming platforms from the console manufacturers, Software offering new and pre-owned gaming software for current and certain prior generation consoles and sell a wide range of in-game digital currency, digital downloadable content and full-game downloads, and Collectibles consist of apparel, toys, trading cards, gadgets and other retail products for pop culture and technology enthusiasts and collectibles related services, such as submission services for the authentication and grading of trading cards. The company operates its business in three geographic segments: the United States, Australia, and Europe.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: